-
Drugs for Life: How Pharmaceutical Companies Define Our Health
- Experimental Futures
- Narrated by: John Brancy
- Length: 8 hrs and 44 mins
- Unabridged Audiobook
- Release date: 07-31-13
- Language: English
- Publisher: University Press Audiobooks
- Whispersync for Voice-ready
Regular price: $19.95
People who bought this also bought...
-
An American Sickness
- How Healthcare Became Big Business and How You Can Take It Back
- By: Elisabeth Rosenthal
- Narrated by: Nancy Linari
- Length: 13 hrs and 38 mins
- Unabridged
-
Overall4.5 out of 5 stars 569
-
Performance4.5 out of 5 stars 512
-
Story4.5 out of 5 stars 509
It is well documented that our health-care system has grave problems, but how, in only a matter of decades, did things get this bad? Dr. Elisabeth Rosenthal doesn't just explain the symptoms; she diagnoses and treats the disease itself. Rosenthal spells out in clear and practical terms exactly how to decode medical doublespeak, avoid the pitfalls of the pharmaceuticals racket, and get the care you and your family deserve. She takes you inside the doctor-patient relationship, explaining step by step the workings of a profession sorely lacking transparency.
-
5 out of 5 stars
-
Well Researched, Outlined, and Presented
- By Craig Schorling on 06-17-17
-
The Truth About the Drug Companies
- How They Deceive Us and What to Do About it
- By: Marcia Angell
- Narrated by: Kate Reading
- Length: 7 hrs and 19 mins
- Unabridged
-
Overall4 out of 5 stars 123
-
Performance4 out of 5 stars 58
-
Story4 out of 5 stars 55
In this explosive expose of the drug companies and how they are ripping us off, Marcia Angell, M.D., a doctor, medical journalist, and a former editor of the respected New England Journal of Medicine, reveals the many ways in which the pharmaceutical industry has moved away from its original purpose of finding and producing useful new drugs.
-
3 out of 5 stars
-
Screed Against the Pharmaceutical Companies
- By Douglas C. Bates on 12-16-12
-
Blockbuster Drugs
- The Rise and Decline of the Pharmaceutical Industry
- By: Jie Jack Li
- Narrated by: Susannah Tyrrell
- Length: 6 hrs and 37 mins
- Unabridged
-
Overall4 out of 5 stars 33
-
Performance4 out of 5 stars 31
-
Story4 out of 5 stars 30
Blockbuster drugs - each of which generates more than a billion dollars a year in revenue - have revolutionized the industry since the early 1980s, when sales of Tagamet alone transformed a minor Philadelphia-based firm into the world's ninth-largest pharmaceutical company. In Blockbuster Drugs, Jie Jack Li tells the fascinating stories behind the discovery and development of these highly lucrative medicines, while also exploring the tumult the industry now faces as the "patent cliff" nears.
-
2 out of 5 stars
-
Great topic, but poor writing and bad performance
- By Jacob Brenner on 05-01-15
-
Bad Blood
- Secrets and Lies in a Silicon Valley Startup
- By: John Carreyrou
- Narrated by: Will Damron
- Length: 11 hrs and 36 mins
- Unabridged
-
Overall5 out of 5 stars 7,027
-
Performance5 out of 5 stars 6,372
-
Story5 out of 5 stars 6,361
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes' worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
-
5 out of 5 stars
-
Excellent listen & definitive account
- By Michael J Canning on 06-30-18
-
Curing Medicare
- A Doctor's View on How Our Health Care System Is Failing Older Americans and How We Can Fix It
- By: Andy Lazris
- Narrated by: Darryl Hughes Kurylo
- Length: 10 hrs and 18 mins
- Unabridged
-
Overall5 out of 5 stars 2
-
Performance4 out of 5 stars 2
-
Story5 out of 5 stars 1
Andy Lazris, MD, is a practicing primary care physician who experiences the effects of Medicare policy on a daily basis. As a result, he believes that the way we care for our elderly has taken a wrong turn and that Medicare is complicit in creating the very problems it seeks to solve. Aging is not a disease to be cured; it is a life stage to be lived. Lazris argues that aggressive treatments cannot change that fact but only get in the way and decrease quality of life.
-
5 out of 5 stars
-
must read for caregivers of the elderly
- By B. Hlavka on 11-23-17
-
The Master Algorithm
- How the Quest for the Ultimate Learning Machine Will Remake Our World
- By: Pedro Domingos
- Narrated by: Mel Foster
- Length: 13 hrs and 3 mins
- Unabridged
-
Overall4.5 out of 5 stars 1,198
-
Performance4.5 out of 5 stars 1,030
-
Story4.5 out of 5 stars 1,027
Under the aegis of machine learning in our data-driven machine age, computers are programming themselves and learning about - and solving - an extraordinary range of problems, from the mundane to the most daunting. Today it is machine learning programs that enable Amazon and Netflix to predict what users will like, Apple to power Siri's ability to understand voices, and Google to pilot cars.
-
3 out of 5 stars
-
Let the Data Speak for themselves
- By Gary on 10-16-15
-
An American Sickness
- How Healthcare Became Big Business and How You Can Take It Back
- By: Elisabeth Rosenthal
- Narrated by: Nancy Linari
- Length: 13 hrs and 38 mins
- Unabridged
-
Overall4.5 out of 5 stars 569
-
Performance4.5 out of 5 stars 512
-
Story4.5 out of 5 stars 509
It is well documented that our health-care system has grave problems, but how, in only a matter of decades, did things get this bad? Dr. Elisabeth Rosenthal doesn't just explain the symptoms; she diagnoses and treats the disease itself. Rosenthal spells out in clear and practical terms exactly how to decode medical doublespeak, avoid the pitfalls of the pharmaceuticals racket, and get the care you and your family deserve. She takes you inside the doctor-patient relationship, explaining step by step the workings of a profession sorely lacking transparency.
-
5 out of 5 stars
-
Well Researched, Outlined, and Presented
- By Craig Schorling on 06-17-17
-
The Truth About the Drug Companies
- How They Deceive Us and What to Do About it
- By: Marcia Angell
- Narrated by: Kate Reading
- Length: 7 hrs and 19 mins
- Unabridged
-
Overall4 out of 5 stars 123
-
Performance4 out of 5 stars 58
-
Story4 out of 5 stars 55
In this explosive expose of the drug companies and how they are ripping us off, Marcia Angell, M.D., a doctor, medical journalist, and a former editor of the respected New England Journal of Medicine, reveals the many ways in which the pharmaceutical industry has moved away from its original purpose of finding and producing useful new drugs.
-
3 out of 5 stars
-
Screed Against the Pharmaceutical Companies
- By Douglas C. Bates on 12-16-12
-
Blockbuster Drugs
- The Rise and Decline of the Pharmaceutical Industry
- By: Jie Jack Li
- Narrated by: Susannah Tyrrell
- Length: 6 hrs and 37 mins
- Unabridged
-
Overall4 out of 5 stars 33
-
Performance4 out of 5 stars 31
-
Story4 out of 5 stars 30
Blockbuster drugs - each of which generates more than a billion dollars a year in revenue - have revolutionized the industry since the early 1980s, when sales of Tagamet alone transformed a minor Philadelphia-based firm into the world's ninth-largest pharmaceutical company. In Blockbuster Drugs, Jie Jack Li tells the fascinating stories behind the discovery and development of these highly lucrative medicines, while also exploring the tumult the industry now faces as the "patent cliff" nears.
-
2 out of 5 stars
-
Great topic, but poor writing and bad performance
- By Jacob Brenner on 05-01-15
-
Bad Blood
- Secrets and Lies in a Silicon Valley Startup
- By: John Carreyrou
- Narrated by: Will Damron
- Length: 11 hrs and 36 mins
- Unabridged
-
Overall5 out of 5 stars 7,027
-
Performance5 out of 5 stars 6,372
-
Story5 out of 5 stars 6,361
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes' worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
-
5 out of 5 stars
-
Excellent listen & definitive account
- By Michael J Canning on 06-30-18
-
Curing Medicare
- A Doctor's View on How Our Health Care System Is Failing Older Americans and How We Can Fix It
- By: Andy Lazris
- Narrated by: Darryl Hughes Kurylo
- Length: 10 hrs and 18 mins
- Unabridged
-
Overall5 out of 5 stars 2
-
Performance4 out of 5 stars 2
-
Story5 out of 5 stars 1
Andy Lazris, MD, is a practicing primary care physician who experiences the effects of Medicare policy on a daily basis. As a result, he believes that the way we care for our elderly has taken a wrong turn and that Medicare is complicit in creating the very problems it seeks to solve. Aging is not a disease to be cured; it is a life stage to be lived. Lazris argues that aggressive treatments cannot change that fact but only get in the way and decrease quality of life.
-
5 out of 5 stars
-
must read for caregivers of the elderly
- By B. Hlavka on 11-23-17
-
The Master Algorithm
- How the Quest for the Ultimate Learning Machine Will Remake Our World
- By: Pedro Domingos
- Narrated by: Mel Foster
- Length: 13 hrs and 3 mins
- Unabridged
-
Overall4.5 out of 5 stars 1,198
-
Performance4.5 out of 5 stars 1,030
-
Story4.5 out of 5 stars 1,027
Under the aegis of machine learning in our data-driven machine age, computers are programming themselves and learning about - and solving - an extraordinary range of problems, from the mundane to the most daunting. Today it is machine learning programs that enable Amazon and Netflix to predict what users will like, Apple to power Siri's ability to understand voices, and Google to pilot cars.
-
3 out of 5 stars
-
Let the Data Speak for themselves
- By Gary on 10-16-15
Publisher's Summary
Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs.
The book is published by Duke University Press.
What members say
Average Customer Ratings
Overall
-
4.5 out of 5 stars
-
5 Stars9
-
4 Stars3
-
3 Stars1
-
2 Stars2
-
1 Stars0
Performance
-
4 out of 5 stars
-
5 Stars4
-
4 Stars6
-
3 Stars1
-
2 Stars1
-
1 Stars0
Story
-
4 out of 5 stars
-
5 Stars6
-
4 Stars2
-
3 Stars1
-
2 Stars1
-
1 Stars1
-
Overall2 out of 5 stars
-
Performance4 out of 5 stars
-
Story3 out of 5 stars
- Laurie
- Florence, KY, United States
- 08-29-15
Snoozefest
I work in the industry, so I am interested in books written about pharmaceuticals. This book is mind numbing, however. The author brings up many interesting points, but it just so boring and flat that the phone book would have held my interest more. If I hadn't just returned the previous book, I would have asked for my credit back for this one. Skip it.
1 of 2 people found this review helpful